Aims & Scope

Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization.

Vaccines publishes high quality reviews, regular research papers, communications and case reports.

Our aim is to encourage scientists to publish their experimental and theoretical results in open access form in as much detail as possible.

The full experimental details must be provided so that the results can be reproduced.

There are, in addition, unique features of this journal: -manuscripts regarding research proposals and research ideas will be particularly welcomed -computed data or files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material -we also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds Subject Areas: -immunology mechanisms- animal models for immunologic diseases- viral immunology- immunopathogenesis- vaccine development and efficacy evaluation- immune responses to vaccines- vaccine technology- vaccine vectors, adjuvants and immunomodulators- prophylactic vaccines, therapeutic vaccines, AIDS vaccines, gene vaccines, vaccines in bioterrorism- regulatory affairs, commercial utilization, policy, safety, epidemiology.

View Aims & Scope

Metrics & Ranking

SJR (SCImago Journal Rank)

Year Value
2024 1.024

Quartile

Year Value
2024 Q1

h-index

Year Value
2024 97

Impact Factor

Year Value
2024 5.20

Journal Rank

Year Value
2024 4641

Journal Citation Indicator

Year Value
2024 22435

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.


Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.


APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Immunology and Microbiology, Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,700.00 CHF. Learn more.

Explore journals without APCs for alternative publishing options.


Quick Facts

Current Factor
5.20
First Published: 2024

SJR (SCImago Journal Rank)

SJR
1.024
First Published: 2024

Quartile

Current Quartile
Q1
First Published: 2024

Similar Journals

Top Journals in Related Fields